AI-Powered News AnalysisCompare coverage across the political spectrum
Back to Dashboard
Lawmakers clash with RFK Jr as he shifts focus away from vaccines

Lawmakers clash with RFK Jr as he shifts focus away from vaccines

During a three-hour hearing, the US health secretary tried to focus on chronic disease while being pressed on vaccines.

April 16, 2026 at 05:55 PM Original source
6 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
1 articles
Lean Left
3 articles
Center
2 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

All Coverage

Lawmakers clash with RFK Jr as he shifts focus away from vaccines
BBC Newsvia rss

During a three-hour hearing, the US health secretary tried to focus on chronic disease while being pressed on vaccines.

100%
Axiosvia ai

Health Secretary Robert F. Kennedy Jr. returns to Capitol Hill after more than six months, now with reduced political influence and autonomy. He is set to appear before the House Ways and Means and Appropriations committees, followed by additional Senate hearings next week. Kennedy’s political standing has weakened due to setbacks in both court and within the Biden administration, affecting his "Make America Healthy Again" movement. Although his prepared remarks highlight achievements like pharmaceutical pricing deals and improved dietary guidelines, they avoid mention of vaccines—a controversial topic linked to past criticisms. Expectation is high for contentious discussions around vaccine policies, especially as Kennedy has previously clashed with critics during hearings. Senator Bill Cassidy (R-La.), who has a strained relationship with Kennedy and faces a significant primary challenge, will be a key figure to watch. Additionally, Senator Shelley Moore Capito (R-W.Va.) aims to verify that critical health program funding remains consistent. Many Republicans are reportedly frustrated with Kennedy, viewing him as a political risk with midterm elections approaching.

80%
RFK Jr. rewrites CDC panel's charter, opening door to anti-vaccine quacks
Ars Technicavia ai

Health Secretary Robert F. Kennedy Jr. has significantly rewritten the charter for a federal vaccine advisory panel, giving him more power to appoint his like-minded allies as federal advisors, shift the panel’s focus to alleged vaccine injuries and risks, and welcome fringe groups and anti-vaccine organizations to the Centers for Disease Control and Prevention. The new charter reveals new responsibilities that redirect advisors toward topics and terms dear to anti-vaccine activists, such as considering analysis of cumulative effects of vaccines and their constituent components, monitoring mRNA vaccines, and reviewing vaccination schedules by other countries and international organizations.

80%
Vaccine critics keep the pressure on, even as RFK Jr. shifts focus
WUSFvia ai

Despite Health Secretary Robert F. Kennedy Jr.'s shift away from vaccine discussions, vaccine critics continue to pressure him. At a recent meeting of the MAHA Institute, vaccine critics argued that injuries from immunizations are an epidemic, highlighting ongoing tensions between Kennedy and vaccine opponents.

80%
Federal judge blocks RFK Jr’s overhaul of vaccine recommendations
The Guardianvia ai

A federal judge blocked a set of changes to the childhood vaccine schedule recommended by allies of Health and Human Services Secretary Robert F. Kennedy Jr., dealing a setback to the Trump administration's efforts to overhaul federal vaccine policy. The judge ruled that the unprecedented changes to routine US immunization recommendations were 'arbitrary and capricious' and likely violated federal law.

80%
The Washington Postvia ai

Health Secretary Robert F. Kennedy Jr. is focusing on food-related initiatives and drug pricing over vaccines, an issue GOP pollsters see as a liability ahead of the midterm elections. This shift comes as the administration downplays its push to overhaul vaccine policy and instead touts its work on food and drug pricing.

80%